- Home
- Publications
- Publication Search
- Publication Details
Title
Juvenile idiopathic arthritis and malignancy
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 53, Issue 6, Pages 968-974
Publisher
Oxford University Press (OUP)
Online
2013-11-02
DOI
10.1093/rheumatology/ket318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
- (2013) Josef S Smolen et al. LANCET
- What is the Background Incidence of Malignancy in Children with Rheumatic Disease?
- (2013) Melissa L. Mannion et al. Current Rheumatology Reports
- Tumor necrosis factor inhibitors and cancer in juvenile idiopathic arthritis: Disentangling the web
- (2012) Karen B. Onel et al. ARTHRITIS AND RHEUMATISM
- Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
- (2012) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents
- (2012) Beth L. Nordstrom et al. ARTHRITIS CARE & RESEARCH
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis
- (2011) X. Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results
- (2011) D. H. Solomon et al. ARTHRITIS AND RHEUMATISM
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
- (2011) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Malignancies in Juvenile Idiopathic Arthritis: A Preliminary Report
- (2011) S. BERNATSKY et al. JOURNAL OF RHEUMATOLOGY
- Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010
- (2011) MARIEKE H. OTTEN et al. JOURNAL OF RHEUMATOLOGY
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
- (2011) Timothy Beukelman et al. ARTHRITIS CARE & RESEARCH
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs
- (2010) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Should the food and drug administration warning of malignancy in children receiving tumor necrosis factor α blockers change the way we treat children with juvenile idiopathic arthritis?
- (2010) Thomas J. A. Lehman ARTHRITIS AND RHEUMATISM
- Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
- (2010) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study
- (2010) J. F. Simard et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
- (2010) Peter Diak et al. ARTHRITIS AND RHEUMATISM
- The safety profile of biologic therapies for juvenile idiopathic arthritis
- (2010) Philip J. Hashkes et al. Nature Reviews Rheumatology
- JIA, treatment and possible risk of malignancies
- (2010) Nicolino Ruperto et al. Nature Reviews Rheumatology
- Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
- (2010) Randy Q Cron et al. Pediatric Rheumatology
- Summary of worldwide pediatric malignancies reported after exposure to etanercept
- (2010) Peter McCroskery et al. Pediatric Rheumatology
- Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
- (2010) T. R. Southwood et al. RHEUMATOLOGY
- Report on malignancies in the German juvenile idiopathic arthritis registry
- (2010) G. Horneff et al. RHEUMATOLOGY
- Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis
- (2009) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
- (2009) E. H. Giannini et al. ARTHRITIS AND RHEUMATISM
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
- (2008) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
- (2008) G Horneff et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
- (2008) Norman Ilowite et al. CLINICAL RHEUMATOLOGY
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Focus on adverse events of tumour necrosis factor blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
- (2007) V Gerloni et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now